Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies.

Brown KL, Lubieniecka JM, Armaroli G, Kessel K, Gibson KM, Graham J, Liu D, Hancock REW, Ross CJ, Benseler SM, Luqmani RA, Cabral DA, Foell D, Kessel C.

Front Pediatr. 2018 Nov 23;6:341. doi: 10.3389/fped.2018.00341. eCollection 2018.

2.

Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.

Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.

Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.

3.

Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RSM, Toth MB, Shenoi S, Ristic G, Nielsen SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; ARChiVe Investigators Network within the PedVas Initiative.

Arthritis Rheumatol. 2017 Jul;69(7):1470-1479. doi: 10.1002/art.40112. Epub 2017 Jun 9.

4.

Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.

Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative.

Arthritis Rheumatol. 2016 Oct;68(10):2514-26. doi: 10.1002/art.39729.

5.

A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor.

Lubieniecka JM, Graham J, Heffner D, Mottus R, Reid R, Hogge D, Grigliatti TA, Riggs WK.

Front Genet. 2013 Nov 11;4:231. doi: 10.3389/fgene.2013.00231. eCollection 2013.

6.

A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin.

Bains OS, Szeitz A, Lubieniecka JM, Cragg GE, Grigliatti TA, Riggs KW, Reid RE.

J Pharmacol Exp Ther. 2013 Nov;347(2):375-87. doi: 10.1124/jpet.113.206805. Epub 2013 Aug 30.

PMID:
23995598
7.

Single-nucleotide polymorphisms in reductase genes are not associated with response to daunorubicin-based remission induction.

Lubieniecka JM, Liu J, Graham J, Heffner D, Reid R, Hogge D, Grigliatti TA, Riggs WK.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1918-20. doi: 10.1158/1055-9965.EPI-13-0671. Epub 2013 Jul 23.

8.

Single-nucleotide polymorphisms in aldo-keto and carbonyl reductase genes are not associated with acute cardiotoxicity after daunorubicin chemotherapy.

Lubieniecka JM, Liu J, Heffner D, Graham J, Reid R, Hogge D, Grigliatti TA, Riggs WK.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2118-20. doi: 10.1158/1055-9965.EPI-12-1037. Epub 2012 Sep 20.

9.

Validation of a sequential extraction and liquid chromatography-tandem mass spectrometric method for determination of dihydrotestosterone, androstanediol and androstanediol-glucuronide in prostate tissues.

Adomat HH, Bains OS, Lubieniecka JM, Gleave ME, Guns ES, Grigliatti TA, Reid RE, Riggs KW.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:84-95. doi: 10.1016/j.jchromb.2012.06.031. Epub 2012 Jul 1.

PMID:
22818945
10.

Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats.

Lubieniecka JM, Streijger F, Lee JH, Stoynov N, Liu J, Mottus R, Pfeifer T, Kwon BK, Coorssen JR, Foster LJ, Grigliatti TA, Tetzlaff W.

PLoS One. 2011 Apr 29;6(4):e19247. doi: 10.1371/journal.pone.0019247.

11.

Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism.

Bains OS, Karkling MJ, Lubieniecka JM, Grigliatti TA, Reid RE, Riggs KW.

J Pharmacol Exp Ther. 2010 Mar;332(3):755-63. doi: 10.1124/jpet.109.160614. Epub 2009 Dec 9.

PMID:
20007405
12.

Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.

Liu S, Cheng H, Kwan W, Lubieniecka JM, Nielsen TO.

Mol Cancer Ther. 2008 Jun;7(6):1751-61. doi: 10.1158/1535-7163.MCT-07-0560.

13.

Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.

Lubieniecka JM, de Bruijn DR, Su L, van Dijk AH, Subramanian S, van de Rijn M, Poulin N, van Kessel AG, Nielsen TO.

Cancer Res. 2008 Jun 1;68(11):4303-10. doi: 10.1158/0008-5472.CAN-08-0092.

14.

cDNA microarray-based translational research in soft tissue sarcoma.

Lubieniecka JM, Nielsen TO.

J Surg Oncol. 2005 Dec 15;92(4):267-71.

PMID:
16299802
15.

Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models.

Terry J, Lubieniecka JM, Kwan W, Liu S, Nielsen TO.

Clin Cancer Res. 2005 Aug 1;11(15):5631-8.

16.

Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study.

Lubieniecka JM, Cheteri MK, Stanford JL, Ostrander EA.

Prostate. 2004 Jun 1;59(4):357-9.

PMID:
15065083

Supplemental Content

Loading ...
Support Center